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COMPARISON OF STANDARD OPERATING PROCEDURES USED 
FOR THE DETECTION OF OPIOIDS IN BLOOD 
KA KIU NATALIE LAW 
ABSTRACT 
 In forensic toxicology, opioids are frequently associated with drug abuse or drug-
related death cases. An optimal method for use in the identification and quantification of 
opioids in a complex blood matrix is of paramount importance. Along with the ability to 
identify and quantitate opioids, this method should be accurate, sensitive, and selective. 
The application of sample pre-treatment and solid-phase extraction are common to purify 
and concentrate the target analytes before analyzing with liquid chromatography-tandem 
mass spectrometry.  
 The purpose of this study was to compare the performance of two standard 
operating procedures, adopted by the Massachusetts State Police Crime Laboratory 
Toxicology and the Biomedical Forensic Sciences– Toxicology Laboratory at Boston 
University School of Medicine, for detecting opioids in blood. A total of eight drugs were 
analyzed: 6-monoacetylmorphine, codeine, fentanyl, hydrocodone, morphine, 
norhydrocodone, oxycodone, and oxymorphone. Comparison was performed using the 
parameters studied as part of method validation, including calibration model, bias, 
precision, carryover, interferences, ionization suppression/enhancement, and recovery.  
 The results indicated that the method from Massachusetts State Police provided a 
better performance with between-run precision, interferences from matrix and other 
commonly encountered drugs, matrix effect at high concentration (250 ng/mL) and matrix 
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recovery. Meanwhile, the method from Biomedical Forensic Sciences showed less bias, 
within-run precision, and matrix effect at low concentrations. Carryover and internal 
standard interference were comparable in both standard operating procedures. The 
calibration models were adjusted by altering the selection of regression model for improved 
quantification method performance. The volume of solvents, sample matrix, as well as 
time, were taken into consideration in accessing the overall performance of identification 
and quantitation. Both procedures were comparable yet the one from Massachusetts State 
Police was more beneficial in identifying the target analytes with greater sensitivity and 
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 In forensic toxicology, the methods to analyze alcohol, drugs, or other toxic 
substances in biological specimens are expected to be effective, selective, and credible. 
The degree of intoxication and therapeutic or toxic effects impact the medicolegal system 
directly. Knowledge of pharmacokinetics, physiochemical properties and interaction of 
drugs are fundamental factors considered to develop an optimal analytical method.1 
Considering the efficacy of isolating drugs and poisons from biological materials, the 
origins of samples and the components of the matrices have to be evaluated as well. 
Therefore, sample preparation is necessary and shall be capable of extracting, purifying 
and concentrating the analytes of interest.   
Sample preparation aims to be a fast, cost effective, and simple prior to 
instrumental analysis.1 Traditional liquid-liquid extraction (LLE) works with a wide 
range of compounds, however, it requires large volumes of organic solvent. Solid phase 
extraction (SPE) was then introduced in the 1960s to substitute the use of LLE. Its unique 
advantages of high recovery, time-saving, more effective concentration, and automation 
have given rise to the continued development and use of SPE methodology.1-3  
A reliable qualitative and quantitative analytical tool is correspondingly essential 
in interpreting the use of a drug(s) and the possible role of a drug(s) in death.4 Increasing 
use of liquid-chromatography coupled with tandem mass spectrometry (LC-MS/MS) 
provides sensitive and selective identification in contrast with gas chromatography mass 
spectrometry (GC-MS) and limits the possibility of matrix effects.5 It also improves the 
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evaluation of possible drugs in a complex mixture of drug analytes and shortens the time 
for each analysis simultaneously.6  
Although the general procedures of sample preparation have been widely 
developed and validated, variability exists, such as the selection of solvents, the sorbent 
materials in the extraction column, and even the slight changes from manufacture-to-
manufacture, lot-to-lot, as well as batch-to-batch, all of which may contribute to the 
capability of clean analyte extraction.7-10 This could also lead to a propagation of 
uncertainty in the overall analysis. Comparison studies have shown that the mixed-mode 
bonded silica SPE columns from Bond Elut Certify (Santa Clara, CA, U.S.A.) has a 
slightly higher recovery than those from Clean Screen DAU (Bristol, PA, U.S.A.) for 
screening drugs in whole blood.9 The variations can be caused by interactions between 
drugs and sorbents from different manufacturing supply sources suggesting the properties 
of silica and its modification.10  
 Opioids, including the new synthetic opioids and analogs, are taking over in the 
market for drug abusers, with a reported increase in deaths caused by illicit opioids in the 
United States12. According to the crime laboratory data from Washington State, the 
number of cases involving the use of heroin increased from ~850 to 2800 over 10 years.11 
A shift from the use of heroin to fentanyl was observed in 2010 along with the detection 
of the drug and presence of drug paraphernalia at death scenes.12 From 2014 to the first 
quarter of 2019, the number of fentanyl-related deaths grew from approximately 25% to 
90% in Massachusetts.13 National Forensic Laboratory Information System (NFLIS) 
annual report showed that cases related to fentanyl abuse have escalated since 2014 
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regionally, especially in the Northeast and Midwest United States.14 A combination use 
of fentanyl and heroin, cocaine, or other opioids are prevalent in enhancing potency and 
psychoactive effects of drug usage. Under the circumstance of drugs interaction, blood 
samples are often drawn during autopsies to investigate the possible use of opioids 





1.2.1 Classification and Pharmacology  
 Opiates are naturally occurring and semi-synthetic alkaloid analgesics obtained 
from the opium poppy, Papaver somniferum.15 Synthetic opioids are synthesized in a 
laboratory, which is not derived from the opium poppy. They are drugs that mimic the 
pharmacological effects of morphine.16  Morphine and codeine are classified as natural 
opioids, while hydrocodone and oxycodone are semisynthetic opioids derived from 
codeine and thebaine respectively.16 Fentanyl and its analogs are considered synthetic 
opioids.16 All natural and synthetic alkaloids that have morphine-like properties are 
included in the class of opioids.  
 Opioids are used medically to relieve moderate to severe pain from cancer, terminal 
illness, surgery and medical emergencies.16 They are used for their antitussive, 
antidiarrheal and detoxification properties.16 In terms of drug abuse, opioids produce 
sedation, euphoria, hallucinations, tolerance and dependence.16 Furthermore, the use of 
opioids are associated with the risk of respiratory failure, nausea, bradycardia, and 
withdrawal symptoms.16-17  
1.2.2 Structures 
 Morphine shares the polycyclic molecular structure with other opioids (Figure 1). 
A modification of the polycyclic framework can alter the pharmacological properties of 
drug and its potency.16 A new characterization of opioids has evolved based on their drug 
design: phenanthrenes, phenylheptylamines, and phenylpiperidines. Phenanthrenes are 
also called 4,5-epoxymorphinans, including morphine, codeine, hydrocodone, oxycodone, 
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and oxymorphone.16 Phenylheptylamines and phenylpiperidines include methadone and 
fentanyl respectively.16 The minor change in chemical structure can profoundly affect the 
efficacy, effectiveness, toxicity and safety between drugs. For example, the replacement of 
C3 hydroxyl group of morphine, as in heroin and codeine, can reduce the affinity toward 
an opioid receptor that give rise to respiratory depression and analgesia.16  
 
Figure 1. Chemical structures of opioids.16,18  
1.2.3 pH and pKa  
Acid dissociation constant (Ka) is an equilibrium constant referring to the ionization 
of an acid. The negative log of the Ka value is known as the strength of an acid pKa. A lower 
pKa value indicates the acid fully dissociates in water, thus indicating a stronger acid. The 
pKa value also determines the degree of ionization that can occur in a drug under a certain 
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pH condition. When the pH value of the environment equals to the pKa value of the drug, 
the drug is 50% ionized and 50% non-ionized. An alteration to the environment pH brings 
direct impact to the drug’s ionization state, which influences the sample preparation 
technique. Henderson-Hasselbach equation is used to calculate the pKa value16:  
For acid drugs: !" = !$% + '() [+,-+./0]
[-,-2+,-+./0]
  
For basic drugs: !" = !$% + '() [-,-2	+,-+./0]
[+,-+./0]
 
 Altering the pH by one unit, the ratio of non-ionized and ionized drugs 
concentration increases by a factor of 10. As a result, a two-unit change of pKa in pH offers 
approximately 100% of ionization, which enhances the extraction by retaining all possible 
drug analytes and removing matrix compounds and interferences. Opioids are known as 
basic drugs with a pKa value ranging from 6.5 to 8.7.18 When the environmental pH is lower 





1.3 Sample Matrix 
 Bodily fluids, such as blood, urine, and oral fluid, as well as tissue specimens are 
common sample types analyzed in forensic science. Focusing on forensic toxicology, blood 
is one of the most commonly encountered biological matrices. As the physical and 
chemical properties of the matrices are accounted for to evaluate the efficiency and 
effectiveness of analytes extraction, it is crucial to evaluate the composition of every 
matrix. Blood is composed of 45% of blood cells and 55% of plasma. Blood cells consist 
of red blood cells (erythrocytes), white blood cells (leukocytes), and platelets. Plasma is 
mostly water (90%) with a remainder of proteins, organic acids and salts.3 Post-mortem 
blood can be viscous and consists of oily materials that may block SPE cartridges with 
small pore size.4 Different sample preparation techniques are needed for drug analysis 





1.4 Sample Preparation 
 Direct injection of samples or analysis of samples is a common practice in the 
disciplines of forensic sciences, however, a direct injection of biological matrix (mainly 
blood) onto an instrument may not generate useful chromatographic separation and 
detection due to a high concentration of interfering materials, especially to LC application. 
A proper sample preparation will remove unwanted sample matrix components and 
concentrate the analyte of interest, meanwhile it prevents damage to instrumental systems 
and contamination of the column. This gives rise to greater selectivity and sensitivity, 
increased recovery, and increased reproducibility for drug analysis. Sample preparation is 
conducted in three stages: prior to the extraction (sample pre-treatment), during the 
extraction (i.e. SPE), and prior to instrumental analysis (reconstitution).  
1.4.1 Sample Pre-Treatment  
Sample pre-treatment aims to increase the retention of the analyte on the SPE 
sorbent surface by maximizing analyte interaction and minimizing those between the 
unwanted interference and the matrix in the following extraction procedure. The addition 
of organic solvent to the sample helps to disrupt the interface between undesired particles 
and target analytes that interact on the sorbent.19 It also serves to remove large particles 
and proteins from the matrix components in order to diffuse into the pores of the sorbent. 
The pH of the sample is adjusted to optimize the extraction performance with different 
acidity of drugs.19 A pH that is approximately two units away from the pKa is desired to 
reach the quantitative retention and elution of the analyte (Section 1.2.3). In other words, 
lowering the pH by two units for basic drugs while raising it for acidic drugs is 
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recommended.19 The pH of the sample can also impact the sorbent bed. The pH 
environment first alters the ion-exchange sites on the silanol surface, and then affects the 
interaction between analytes and the sorbent.19 A buffer solution is usually added to adjust 
the sample’s pH offering an optimal ionic strength.19  
Centrifugation may be applied to blood samples to reduce viscosity and to separate 
the blood cells from the plasma.3 It also helps filter out particulates and prevent clogging 
the column. Moreover, proteins are present in blood for clot formation; centrifugation of 
clotted-blood sample helps isolate the serum and the cells layer.3 Different protein 
concentration between the plasma and the serum may affect the solubility of drugs and 
their extraction performance.3 For a plasma sample that has been thawed and frozen several 
times, protein clotting is common. Typically, a pH 7.0 phosphate buffer is added to the 
plasma sample for pH control as well as viscosity.3  
1.4.2 Solid Phase Extraction 
1.4.2.1 Principle 
 Solid phase extraction is a popular sample preparation technique that concentrates 
and purifies analytes from solution by sorption on a solid sorbent and elutes analytes from 
the sorbent using an appropriate solvent for instrumental analysis. Therefore, SPE is also 
known as a form of digital liquid chromatography, referring to the on/off mechanism of 
sorption and desorption.20  
 The performance of SPE is greatly influenced by the sorbent and the mechanism of 
sorption. The sorbents can be packaged in disks, cartridges, or syringe barrel.3 The three 




The selective extraction is determined by the interaction between the sorbent and 
the solute, therefore an understanding of the sorbent, also known as the solid phase, is of 
paramount importance. The first sorbent used was XAD resin in 1970s.21 Currently, sorbent 
materials have been switched to the use of chemically modified silica gel and polymer 
sorbents.21 Bonded silica sorbents are made by reacting an organosilane which consists of 
a silicon atom bonded to an organic functional group, with the silica surface, resulting in a 
Si-O-Si-C bond.21 Polymeric sorbents do not contain silica and are entirely organic 
polymers with a higher carbon percentage and a more hydrophobic surface.3 The functional 
groups on the sorbent surface establish the ionic strength, polarity and hydrophobicity with 
the analytes, which influence the retention mechanism.  
 The mode of sorption includes normal phase, reversed phase, ion exchange, and 
size exclusion. Normal-phase SPE refers to the sorption of analytes on a polar surface (i.e. 
cyanopropyl (CN), aminopropyl (NH2), or diol functional groups) along with the use of 
nonpolar mobile phase, involving interactions of hydrogen bonding and dipole-dipole 
interactions.3 Reversed phase mechanism involves the partitioning of analytes from a polar 
mobile phase into a nonpolar sorbent.3 Van der Waal’s forces or dispersion forces is used 
in this nonpolar interaction.3 The common packing materials in a normal-phase sorbent are 
C-8 and C-18 hydrocarbons, as well as C-2, C-4, cyclohexyl, and phenyl groups.3 Ion-
exchange SPE employs the exchange of a charged solute from solvent onto the oppositely 
charged sorbent.3 The hydrophilic ion-exchange sites on a sorbent are capable of the 
exchange for both cations and anions. Cation-exchange sites are silica matrix bonded with 
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sulfonic acid or carboxylic acid (negative charged) that is utilized for the extraction of 
ionized basic compounds (positive charged).3 Anion-exchange sites are composed of 
quaternary amine groups for the extraction of ionized acidic compounds.3 Size exclusion 
is a mechanism that is based on the molecular size of the analyte. It is usually used in 
conjunction with reversed phase or ion exchange. 3 A mixed-mode interaction involving 
reversed phase and ion exchange was introduced for drug analysis in the last decade. The 
packing material typically contains a C-8 bonded silica gel and a cation-exchange group. 
The alkyl chain serves to retain the acidic and neutral substances by hydrophobic 
interaction and basic substances by cation exchange interaction.3 The mixed-mode sorption 
is applied to most basic and amphoteric drug separations, for example, amphetamine, 
barbiturates, codeine, and fentanyl.  
1.4.2.2 Procedures  
 Generally, there are four basic steps for SPE: 1) conditioning the column 2) 




Figure 2. General steps for solid phase extraction.22  
 The column is first conditioned in order to activate the sorbent surface and remove 
the air and impurities in the column.19 A ratio of three to four bed volumes of solvent to 
the sample volume are usually used to condition the column. The selection of activating 
solvent is dependent to the chemical properties of the packing materials. For example, a 
silica gel modified with long hydrocarbon chain (C-18) is conditioned with an organic 
solvent. The hydrophobic chain will collapse and become extended which will be available 
to interact with the analyte (Figure 3).19 Methanol is a favorable solvent to solvate the 
functional groups of the sorbent and then followed with water and an aqueous buffer.3,19,23 
This allows a better sorption performance with aqueous samples. The polarity, ionic 
strength, and the pH of the sample are taken into account while choosing the solvent to 
reach an equilibrium environment for maximizing the analyte retention time. The column 




Figure 3. Effect of conditioning modified silica surface.19 
 Next, the sample is loaded onto the column by gravity, pump, or by an automated 
system. The loading rate varies depending on the analytes itself and the retention 
mechanism with the sorbent. Analyte is concentrated and retained on the sorbent while 
some interfering components may pass through the column. The amount of contact time 
available for the analyte to the sorbent is a determining factor of analyte recovery.19 The 
flow rate is inversely correlated with the partition coefficients of analyte in reaching the 
equilibrium, resulting in recovery reduction (Figure 4).19 Research has shown that different 
sorption mechanisms suggest different linear velocity for sample loading, for example, ion-
exchange phase should be loaded with a rate of 1 mL/min on a 1 mL extraction cartridge.24   
 
Figure 4. Relationship between flow rate and recovery.19 
 
 14 
 The following step is to rinse the column for interference removal and analyte 
retainment. The selected rinsing solvent has the ability to remove species that could 
interfere with the analytical result without the loss of the target analyte. During the washing 
step, the retention conditions, including the pH and ionic strength, are maintained to avoid 
analyte loss.19 pH can be adjusted to a suitable value for elution.23 An aqueous buffer or an 
organic solvent-water mixture is preferred with an aqueous sample.19 For sample dissolved 
in an organic solvent, the same solvent is suggested for washing. A fraction of organic 
solvent, such as acetic acid, is also recommended to remove additional interferences.19 The 
columns are required to dry under vacuum or with nitrogen gas in order to remove water 
molecules, especially if water immiscible solvents are used, in addition to improve elution 
and recovery.19,23  
 The final step of SPE is to elute the analyte from the sorbent. An appropriate solvent 
with low viscosity, low flammability and toxicity is always preferred.19 However, the most 
important criteria is its strength and selectivity in enhancing the matrix-sorbent, and matrix-
analyte interactions and disrupting the sorbent-analyte interaction.19 The solvent should be 
able to solubilize the analyte for elution. Sorption mechanisms, elution conditions, and 
following procedures should be considered while choosing the elution solvent. For 
example, in a reversed phase extraction, a nonpolar solvent (hexane) has a greater eluting 
strength than a polar solvent (water) on a nonpolar sorbent.3,19 A volatile solvent should be 
picked if the extraction is followed by an evaporation to dryness and reconstitution.19 In 
addition to the solvent selection, sufficient contact time is also needed to maximize analyte 
diffusion from the porous sorbent. A study performed by Raisglid and Burke suggested 
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that a 1-2 minute soaking step between two aliquots of solvent allows analyte elution with 
minimal solvent volumes yet trace enrichment.19  
1.4.3 Sample Collection 
 After the elution step in SPE, the samples may be evaporated to dryness and 
reconstituted with a solvent. An optimal temperature for evaporation is crucial as a study 
reported about a 25% decrease in recoveries at 50°C for most of the analytes examined.25 
Meanwhile the elution solvent also impacts the evaporation temperature used to recover 
most of the compounds. The study found that temperature has an apparent effect in basic 
methanol elution (7% NH4OH/MeOH (v/v), pH 11.8) compared to in methanol-only.26 It 
also suggested that basic methanol has a pH higher than the pKa of the basic drugs, where 
analytes are non-ionized and more non-polar that will increase volatility.26 Opioids such as 
heroin, 6-monoacetylmorphine (6-MAM), codeine, and morphine, showed consistent 
recoveries from 20-60°C in both basic methanol and methanol-only elution.26 Considering 
time consumption and recovery efficacy, an evaporation temperature of 40°C is usually 
selected and done by an evaporator under nitrogen.3,19   
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1.5 Instrumentation Theory 
1.5.1 Liquid Chromatography  
Liquid chromatography (LC) is a separation process employing a liquid mobile 
phase and a stationary phase. It partitions a complex mixture of compounds into smaller 
components according to their differential distribution. The instrument consists of mobile 
phase reservoirs, pumps, injection port, column, column oven and connects to a 
detector.16,27  
Analyte separation process is based on differential affinity of the target analytes 
towards the stationary phase and mobile phase.27 When the sample passes through the LC 
column along, components that have a similar property and greater affinity to the mobile 
phase will elute first.27  
The stationary phase of LC is a metal tube filled with a bed of fine solid particles. 
Most packing materials are silica gel particles, either unmodified or chemically supported 
with non-polar stationary phases.27 Chromatographic separation can be performed in 
normal phase or reversed phase, holding the same principle as SPE (Section 1.4.2.1). 
Normal phase LC has a polar stationary phase and a relatively low polarity (non-polar) 
mobile phase. Conversely, reversed phase chromatography utilizes a non-polar stationary 
phase, usually bonded with C8 or C18, and a polar mobile phase. In reverse phase 
chromatography, the more polar the mobile phase, the longer time for the analyte to retain 
on the stationary phase and elute later.27 A short guard column with the same packing 
material as the analytical column is usually recommended for column protection and 
impurities removal.28  
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The mobile phases used are solvents or mixtures of solvents eluting isocratically or 
in gradient.16,27 Isocratic elution has a constant mobile phase composition.16 Gradient 
elution allows a gradual change in a composition of two or more solvents during the run.16 
As changing the composition, the strength of the mobile phases increases as well, giving a 
better selectivity in separation. Mobile phase of water modified with less polar materials, 
such as methanol or acetonitrile (ACN), is usually applied.16 An addition of volatile acids, 
for example, formic acid or acetic acid, are used to improve ionization in mass 
spectrometry.  
1.5.2 Tandem Mass Spectrometry 
 Mass spectrometry (MS) is a powerful technique used to identify the components 
of a sample.16 The compounds are first fragmented and ionized by an ion source, then the 
physical chemical properties of their mass (m) and charge (z) are allowed for separation 
within a mass analyzer. A unique signal is generated from a detector to represent the ion 
and its abundancy. Finally, a mass spectrum is collected and captured by a data system.  
 A sample has to be introduced to the mass spectrometer prior to the mass analyses, 
however, direct insertion has limitations.16 Therefore, interfacing LC with a mass 
spectrometer is commonly used. The LC effluent undergoes different ionization techniques 
to be available for transfer into the mass spectrometer. Electrospray ionization (ESI) is a 
type of ionization technique related to atmospheric-pressure ionization (API).16 ESI 
produces ions by transferring energy (charge) to the analyte droplets and completing 
desolvation with a heated capillary (Figure 5).29 The droplets decrease in size, which break 
the surface tension of the spherical droplets and the Coulomb force of repulsion, into much 
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smaller droplets (Figure 5).29 The gas-phase charged species are subsequently detected by 
an analyzer.29 Quadrupole is a common mass analyzer using a combination of radio 
frequency (rf) and direct current (DC) voltages on two sets of diagonal rods.16 Ions with a 
specific mass-to-charge (m/z) value are selected to pass through the analyzer to the 
detector. ESI is a soft ionization technique that does not fragment macromolecules into 
smaller charged particles and will produce less chemical structural information about the 
molecules.16 The use of a tandem mass analysis can overcome the problem of little 
structural information.28  
 
Figure 5. Schematic representation of the electrospray ionization process.29  
 Tandem mass spectrometry (MS/MS) can occur in space or in time.16,30 MS/MS in 
space utilizes three quadrupole mass analyzers in series, as known as the triple quads 
(qQq). The first quadrupole (Q1) is the mass filter that only allows targeted m/z ions to 
pass through, which is referred to the precursor ion.30 Quadrupole two (Q2) is the collision 
cell where inert gas such as nitrogen generates collisions between gas molecules and 
filtered ions to form fragmentation.30 Fragmented ions, also named as the product ions, are 
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scanned or selectively filtered in the third quadrupole (Q3) for further detection and 
analysis.30 With the scanning mode of multiple reaction monitoring (MRM), several 
precursor ions and their corresponding product ions from a sample can be selected and 
identified, which can identify and quantify small amounts of analytes in complex matrices 
simultaneously.28  
 LC-MS/MS has become a gold standard of routine quantification with good 
specificity and sensitivity in pharmacokinetic studies.31 It also has the ability to determine 
a wide range of substances, exhibiting the properties of ionic, polar, thermally labile, non-
volatile, and high molecular weight, without derivatization.15 In the conjunction with 
MS/MS, coeluting species are isolated from the mass spectra of targeted analytes based on 
the molecular ion and the parent-to-product transition ions, which enhances the accuracy 
of identification.   
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1.6 Research Objectives 
 The purpose of this research is to compare the performance of opioids analysis in 
blood using two different standard operating procedures (SOP). Eight opioids, including 
6-MAM, codeine, morphine, fentanyl, hydrocodone, norhydrocodone, oxycodone, and 
oxymorphone, are analyzed in this comparison study. The SOP from Massachusetts State 
Police (MSP) also identifies and quantifies acetyl fentanyl, hydromorphone, and 
norhydrocodone, which are not included in this study. Although the general procedures 
applied from MSP Crime Laboratory Toxicology Unit and Boston University School of 
Medicine Biomedical Forensic Sciences (BMFS) – Toxicology Laboratory are the same: 
the volume of solvents, the volume of sample matrix, and other parameters are different in 
sample preparation as well as the settings for calibration model used for quantitation. 
Modifications were also made while using the MSP’s method according to the laboratory 
setting and instrumentation for a parallel comparison with the BMFS’s SOP. The 
alterations include the type of LC column, working stock solution preparation, the 
concentration of the calibration range, and the transition ions in MS/MS method. A 
comparison of two SOPs was completed based on method validation parameters set forth 
in the Academy Standards Board (ASB) guidelines32. The parameters performed were 
calibration model, bias, precision, carryover, matrix interference, internal standard 
interferences, other commonly encountered drugs interference, ionization suppression/ 




2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Standards/Reagents 
Drug standards and their respective deuterated internal standards were purchased 
from Cerilliant Corporation (Round Rock, TX, U.S.A.) and Lipomed AG (Arleshiem, 
Switzerland). All standards used and lot numbers were listed in Table 1. Drug standards 
and internal standards were diluted into working stock solutions at different concentrations.  
LC optima grade methanol (MeOH), LC optima grade acetonitrile (ACN), optima 
methylene chloride (DCM), optima grade 2-propanol (isopropanol/ IPA), and American 
Chemical Society (ACS) certified ammonium hydroxide (NH4OH) were purchased from 
Fisher Scientific (Waltham, MA, U.S.A.). Glacial reagent grade ACS acetic acid, sodium 
phosphate dibasic anhydrous (Na2HPO4), and sodium phosphate monobasic monohydrate 
(NaH2PO4×H2O) were purchased from Acros Organics (Pittsburgh, PA, U.S.A.).  Formic 
acid was purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Deionized (DI) water 
used was obtained from Milli-QÒ Type 1 Ultrapure Water Systems from MilliporeSigma 
(Burlington, MA, U.S.A.). 100mM phosphate buffer (pH 6.0), 100mM acetic acid, 78/20/2 
(v/v/v) DCM/IPA/NH4OH, 0.1% formic acid in water/ACN (95/5), 0.1% formic acid in 




Table 1. Drug Standard Lot Numbers 
Compound Lot # Cerilliant Lipomed 
6-MAM - 43.1B8.1L2 
6-MAM-d6 - 981.1B1.1L4A 
Codeine - 69.1B0.1L5 
Codeine-d3 - 41.1B11.3L3 
Morphine - 35.1B0.1L11 
Morphine-d6 FE09081702 - 
Fentanyl - 622.2B27.1L2 
Fentanyl-d5 - 1280.1B1.1L3A 
Hydrocodone - 405.1B4.1L2 
Hydrocodone-d6 - 1208.1B7.1L3 
Norhydrocodone - 846.1B10.1L1 
Norhydrocodone-d3 - 1645.1B1.1L2A 
Oxycodone - 404.1B0.3L2 
Oxycodone-d3 FE07251804 - 
Oxymorphone - 406.1B6.1L1 





2.1.2 Extraction Columns 
Clean ScreenÒ DAU (CSDAU206) solid phase extraction (SPE) columns from 
United Chemical Technologies (UCT) (Bristol, PA, U.S.A.) were used in this study.  
2.1.3 Specimens 
Blank human blood was purchased from Equitech Enterprises (Kerrville, TX, 
U.S.A.), Biological Specialty Corporation (Colmar, PA, U.S.A.), and Boston Medical 
Center Blood Bank (Boston, MA, U.S.A.). 
2.1.4 Equipment 
For in-house reagent preparation, an OkatonÔ pH 700 benchtop meter from Fisher 
Scientific was utilized in the buffer solution. A SorvallÔ ST 8 Centrifuge from Thermo 
ScientificÔ and a Positive Pressure Manifold from UCT were used for sample preparation 
and solid phase extraction. A MULTIVAP Nitrogen Evaporator from Organomation 
(Berlin, MA, U.S.A.) was also used in drying samples. 
2.1.5 LC-MS/MS Instrumentation and Software 
 All analyses were performed on a Shimadzu (Kyoto, Japan) Ultra-Fast Liquid 
Chromatography (UFLC) coupled with a SCIEX (Framingham, MA, U.S.A.) 4000 
QTRAPÒ MS/MS. The UFLC system included a CBM-20A LC system controller, two 
pumps of LC-20ADSP, DGU-20A3R degassing unit, a SIL-20ACHT autosampler, and a 
CTO-20A column oven. The 4000 QTRAPÒ system is a hybrid triple quadrupole/ linear 
ion trap tandem mass spectrometer with a Turbo VÔ source for ESI. The chromatographic 
column used was Kinetex F5 2.6 µ 100 Å 50 x 3.0 mm from Phenomenex (Torrance, CA, 
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U.S.A.). Data were collected by SCIEX AnalystÒ Software (version 1.6.2) while 





2.2.1 Working Stock Solution Preparation 
Drug standards and internal standards were purchased in either 1 mg/mL or 100 
µg/mL and are listed in Table 2. Eight drug standards were added and diluted in methanol 
to stock solution 1 at 100,000 ng/mL. Stock solution 1 was further diluted in methanol to 
a concentration of 10,000 ng/mL and 1,000 ng/mL as stock solution 2 and 3 respectively. 
The stock solutions were used to produce working calibration (WC) solutions and working 
quality control (WQC) solutions. Calibrators were created at seven points: 5, 10, 25, 50, 
100, 250, 500 ng/mL, for analysis. Three quality control levels were generated as low QC 
(LQC) at 20 ng/mL, mid QC (MQC) at 150 ng/mL, and high QC (HQC) at 200 ng/mL.  
The protocol of MSP suggests the preparation of the WC solutions and WQC 
solutions in a different procedure, however, the final concentrations of all calibrators and 
controls prepared in this study were the same and consistent to both SOPs for comparison.   
















The working internal standard (IS) solution was made up with eight deuterated 




All stock solutions and working solutions are presented in Table 3 with their 
corresponding name and concentration. 
Table 3. Concentration of Solutions 
Solutions Concentration (ng/mL) 
Stock Solution 1 100,000 
Stock Solution 2 10,000 













2.2.2 Sample Pre-treatment 
2.2.2.1 MSP Crime Laboratory 33 
 Addition of 100 µL of working IS solution, 2.5 mL of 100mM phosphate buffer, 
and 500 µL of blank blood to every test tube. Internal standard was not spiked in the double 
blank sample. Test tubes for quality control were added with 50 µL of corresponding 
working QC solution. All the samples were vortexed for ~10 seconds and were centrifuged 
at 3000 rpm for 10 minutes.  
2.2.3.2 BMFS – Toxicology Laboratory 
 The procedures followed were similar to the MSP Crime Laboratory yet with a 
different volume of working solution, buffer, and blood. The working IS solution of 40 µL, 
 
 27 
working QC solution of 20 µL, and 200 µL of 100mM phosphate buffer were spiked to 
200 µL of blank blood in a test tube. The samples were vortexed for ~10 seconds and were 
centrifuged at 4000 rpm for 5 minutes.  
Table 4. Solutions and Parameters for Sample Pre-treatment 
Solutions/ Parameters MSP Crime Laboratory33 BMFS Toxicology 
Laboratory 
Blank Blood 500 µL 200 µL 
Working IS Solution 100 µL 40 µL 
Working QC Solution 50 µL 20 µL 
100mM Phosphate Buffer 2.5 mL 200 µL 
Centrifuge 3000 rpm for 10 minutes 4000 rpm for 5 minutes 
 
2.2.3 Sample Preparation 
2.2.3.1 MSP Crime Laboratory 33 
 SPE columns were first conditioned with 3 mL of methanol, followed by 3 mL of 
deionized (DI) water and 1 mL of 100mM phosphate buffer. Pre-treated sample was then 
applied to the columns. The columns were washed with 3 mL of DI water, 1mL of 100mM 
acetic acid, and 3 mL of methanol. All solutions were added accordingly and allowed to 
flow through the sorbent with gravity. The columns were dried for 5 minutes in a full 
vacuum flow by the positive pressure manifold. After that, an elution solvent of 2 mL 
78:20:2 (v:v:v) DCM:IPA:NH4OH was added to the columns and flowed under gravity. 
The elution solvent was collected in test tubes and evaporated to dryness at 40 °C using an 
evaporator. Lastly, the samples were reconstituted with 100 µL of a 95:5 Reconstitution 




2.2.3.2. BMFS – Toxicology Laboratory  
 Again, the procedures for sample preparation were comparable but in different 
volume. In conditioning the SPE columns, 2 mL of methanol, 2 mL of DI water, and 2 mL 
of 100mM phosphate buffer were loaded correspondingly. After applying the pre-treated 
samples, SPE columns were washed with 2 mL of DI water, 1mL of 100mM acetic acid, 
followed by 1 mL of methanol under gravity flow. The columns were also dried in a full 
vacuum flow for 5 minutes. The elution solvent, 78:20:2 (v:v:v) DCM:IPA:NH4OH, was 
then applied to the columns in 3 mL and was allowed to flow via gravity. The collected 
elution solvent was placed in the evaporator to dryness at 40 °C. Lastly, the samples were 




Table 5. Solutions for Sample Preparation  





MeOH 3 mL 2 mL 
DI water 3 mL 2 mL 
100mM Phosphate  
Buffer 1 mL 2 mL 
Washing 
DI water 3 mL 2 mL 
100mM Acetic Acid 1 mL 1 mL 
MeOH 3 mL 1 mL 
Eluting DCM:IPA:NH4OH 2 mL 3 mL 
Reconstituting 
95:5 (0.1% formic acid in 
water/ 0.1% formic acid in 
ACN) or in Water 
100 µL 400 µL 
 
2.2.4 LC-MS/MS Instrument Parameters 
 A sample injection of 5µL was utilized under binary gradient with a flow rate of 
0.6 mL/min in 0.1% formic acid in DI water (mobile phase A) and in ACN (mobile phase 
B). The time program for LC mobile phase gradient is listed in Table 6 and the parameters 
used in the autosampler are displayed in Table 7. The oven temperature was maintained at 
40°C throughout the entire analysis. The total sample run time was 8.992 minutes.  
 All samples were then ionized in an ESI-MS/MS and detected in MRM scanning 
mode.  In the MRM scanning mode, two product ions labeled as the quantitative (quant) 
and qualitative (qual) were assessed for each analyte for detection. The mass of parent ion 
(Q1), mass of product ions (Q3), the values of declustering potential (DP), collision energy 
(CE), and collision cell exit potential (CXP) are listed in Table 8.  
 Considering the availability and performance of instrumentation in the BMFS- 
Toxicology Laboratory, the LC-MS/MS instrument parameters in this study were set forth 
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by the BMFS’ SOP. The details of the instrument parameters utilized by MSP are listed in 
Appendix C.  
Table 6. LC Mobile Phase Gradient Method 
Time (min) % Mobile Phase A % Mobile Phase B 
0.01 90 10 
0.5 90 10 
3 80 20 
5 60 40 
6.5 30 70 
7.5 0 100 
9.00 0 100 
9.01 95 5 
10.00 Stop 
 
Table 7. Autosampler (SIL-20AC/HT) Parameters 
Injection Volume 5 µL 
Rinsing Volume 1000 µL 
Needle Stroke 52 mm 
Rinsing Speed 35 µL/sec 
Sampling Speed 3.0 µL/sec 
Purge Time 25 min 
Rinse Dip Time 5 sec 
Rinse Mode Before and after aspiration 





Table 8. MS/MS (MRM) Method Parameters  









6-MAM quant 328 165.3 100 54.25 29.53 
6-MAM qual 328 152.1 100 93.16 25.84 
6-MAM-d6 334.1 211.1 100 37.02 35.28 
Codeine quant 300.3 152.1 95 86.6 25.05 
Codeine qual 300.3 115.3 95 101.62 17.56 
Codeine-d3 306.2 152.2 100 89.56 25.15 
Morphine quant 286.3 152.1 91 99 12 
Morphine qual 286.3 115.2 91 101 18 
Morphine-d6 292.3 152 85 80.93 25.49 
Fentanyl quant 337.2 105.1 86 55 18 
Fentanyl qual 337.2 188.3 86 33 10 
Fentanyl-d5 342.2 105.2 90 55.74 17.21 
Hydrocodone quant 300.215 199.1 91 41 32 
Hydrocodone qual 300.215 128 91 81 20 
Hydrocodone-d6 305.7 202.1 115.23 43.87 35.22 
Norhydrocodone 
quant 286.2 199.1 120.69 35.87 28 
Norhydrocodone 
qual 286.2 128.3 120.69 83.38 5.04 
Norhydrocodone-d3 289.15 202.2 93 39 10 
Oxycodone quant 316.2 298.5 80 26.81 23.57 
Oxycodone qual 316.2 241.3 80 41.15 38.73 
Oxycodone-d3 322.1 304.1 80 26.61 17.89 
Oxymorphone quant 302.2 284.2 83.23 29.46 35.29 
Oxymorphone qual 302.2 227.2 83.23 37.04 38.05 





3. COMPARISON PARAMETERS 
3.1 Calibration Model 
 Calibration model represents the relationship between an analyte concentration and 
signal response, in terms of the peak area ratio of analyte and its internal standard.32 It is 
determined by a working range of concentration that is relevant to the method applied. The 
model is established by analyzing at least six matrix-matched calibrators samples at 
different non-zero concentrations over five separate runs. It is then evaluated by the 
coefficient of determination (r2). The evaluation determines the variances across the 
calibration range and indicates whether the chosen regression model is appropriate.  
 In this study, seven calibrators points at the concentration of 5, 10, 25, 50, 100, 250, 
and 500 ng/mL were utilized for all analytes. Although the MSP’s SOP created the 
calibration model from 0.5 ng/mL to 50 ng/mL for 6-MAM and fentanyl, an unite range of 
calibrator’s concentration was used in this study due to the detection and performance of 
the instrument. Different drug analytes were associated with different regression models 
according to the SOP from MSP Crime Laboratory and BMFS Toxicology Laboratory. For 
MSP Crime Laboratory, drug analytes: 6-MAM, morphine, fentanyl, hydrocodone, 
norhydrocodone, oxycodone, and oxymorphone, were calibrated with a linear regression 
model with an inversely weighted concentration (4
5
), while codeine was determined by a 
quadratic regression model. For BMFS Toxicology Laboratory, a linear calibration model 
was preferred for 6-MAM, morphine, hydrocodone, norhydrocodone, and oxymorphone. 
A quadratic calibration model was used in codeine, fentanyl, and oxycodone.   
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3.2 Bias and Precision 
 Bias indicates the closeness between the measurements and the true value of a 
measurand, while precision exhibits the closeness between a series of measurements from 
multiple samplings of the same homogenous sample.32 Bias and precision studies were 
carried out together in evaluating the accuracy, reproducibility, and reliability of a 
validated method. It is measured by a triplicate of three concentration pools (low, medium, 
and high) spiked in the blank matrix samples over five different runs. Particularly for 
precision, both within-run and between-run were conducted and expressed in terms of the 
percentage of coefficient of variation (%CV). Within-run precision focuses on each 
concentration for each of the five runs. Between-run precision emphasizes on each 
concentration over the five runs. Calculated concentration of samples was determined by 
using SCIEX MultiQuantÔ and was used to calculate the bias, precision, and %CV. The 
largest calculated within-run %CV at each concentration was used to assess the precision 
acceptability. The maximum acceptable bias and precision value were set at ± 20% at each 










K × 100 
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K × 100 
In this study, the three concentration points used were 20 ng/mL, 150 ng/mL, and 
200 ng/mL. A calibration curve with seven decision points, a double blank, and a blank 





 Carryover refers to the presence of an analyte signal that represents an unintentional 
component in samples run after analyzing a positive sample. The possibility of carryover 
may lead to an inaccurate qualitative or quantitative result. The evaluation was done by 
running a double blank, where the blank matrix sample has no drug standard and internal 
standard, immediately following the highest calibrator and confirmed with three analyses. 
The maximum acceptable signal of a carryover is limited to 10% of the lowest calibrator’s 
signal at the corresponding retention time.  
 In this study, the signal level of target analyte in the double blank sample was 
examined and compared between two SOPs. The smaller signal is determined as the better 




3.4 Interference Studies 
 Interference demonstrates an impact on detection, identification, and quantification 
of a targeted analyte due to the presence of non-targeted analytes from matrix components, 
internal standard, other drugs and metabolites, and impurities. The area of the detected 
signal was used in comparison with the corresponding area of the limit of quantification 
(LOQ).  
3.4.1 Matrix Interferences 
 Blank matrix samples from ten different sources were analyzed to confirm the 
matrix itself does not contain any interfering components to the target analyte.  
3.4.2 Interferences from Stable-Isotope Internal Standards 
 Internal standards of isotopically-labeled compounds may contain impurities from 
the non-labeled compound and the mass spectra of the internal standard may share the same 
mass-to-charge ratios of fragment ions with the target analyte. Both properties should be 
taken into account for analyte identification and quantification. As a result, a blank matrix 
sample spiked with internal standard was measured and monitored for potential signal of 
the target analyte. Another blank matrix sample with the highest calibrator only was also 
evaluated to ensure that unlabeled compound was not detected as labeled compound 
affecting quantification result.  
3.4.3 Interferences from Other Commonly Encountered Analytes 
 The detection of other commonly encountered analytes should be considered, 
especially in casework involving poly-drug abuse. Analytes of other drugs, metabolites, 
and structurally-similar compounds have a great potential in interfering with the method’s 
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analytes in qualification and quantification. Evaluation was conducted by utilizing fortified 
matrix samples containing other drugs commonly found in forensic toxicology from three 
separate mixes. The drugs contained in the three mixes were listed in Table 9. 
Table 9. Three Mixes for Other Commonly Encountered Analytes Interference 
Mix 1 Mix 2 Mix 3 
Alpha-hydroxyalprazolam Amobarbital Δ9-THC 
Clonazepam Butalbital 11-Hydroxy-Δ9-THC 
7-aminoclonazepam Phenobarbital 11-nor-9-Carboxy-Δ9-THC 
Diazepam AB-FUBINACA 
Etizolam AB-FUBINACA metabolite 3 
Norcocaine AB-FUBINACA metabolite 2a 
Benzoylecogonine AB-PINACA-blood 






3.5 Ionization Suppression/ Enhancement 
 Ionization suppression/ enhancement implies the changes in signal response from 
instrument under the presence of co-eluting compounds. This is also referred to as matrix 
effect. The average suppression or enhancement is expected to be within a 25% range for 
less impact on identifying and quantitating analytes. In this study, a post-extraction 
addition approach was utilized by creating two different sets of samples. One set of samples 
consisted of neat standards at a low concentration (10 ng/mL) and a high concentration 
(250 ng/mL). Each of the neat standards was injected for six times for an average peak 
area. Another set of samples consisted ten different matrix sources in duplicate. Both 
concentrations of standard were fortified in each matrix sample after the extraction 
procedures. The analyte peak areas of both sets were compared in ionization performance 











 Recovery determines the efficiency to recover the target analyte after extraction. It 
is evaluated with ionization suppression/enhancement study concurrently, which also 
includes two sets of samples at low and high concentration. A set of samples using ten 
different matrix sources spiked with standard before extraction procedures is compared 
with another set of fortified samples spiked after extraction. The average area of the signal 




K × 100 
 In this study, the two standard concentrations were 10 ng/mL and 250 ng/mL. 
Fortified samples from ten different sources were prepared before extraction and a 
duplicate of another ten fortified samples were made after extraction. A minimum of 50% 




4. RESULTS AND DISCUSSION 
4.1 Calibration Model 
 Calibration model is always an important determining factor in quantification. 
Concentration of drug analytes is calculated by the calibration curve established correlated 
to its signal response. The working range of the calibration model was set with seven 
calibrators from 5 ng/mL to 500 ng/mL.  
 Coefficient of determination (r2) was calculated by multiplying the correlation 
coefficient (r) twice and the minimum value was preferred to be 0.99. For MSP, fentanyl 
and oxymorphone failed to meet the acceptance criteria of r2 value for all five runs. Four r2 
values of fentanyl were ranging from 0.85 to 0.97 (Table 10). Oxymorphone presented a 
linearity of 0.98 in one run, yet the other six opioids passed the minimum value and with a 
majority of 0.997 or above (Table 10). For BMFS, all eight analytes had their r2 value at 
0.992 or above, excluding norhydrocodone in one of the five replicates (Table 11). Most 
analytes were at least 0.998 (Table 11). 
 Specifically comparing the regression model in fentanyl, MSP used a linear model 
whereas BMFS used a quadratic model, however they displayed variation in performance. 
Fentanyl showed a better working performance in quadratic regression model with the 
instrument at the BMFS-toxicology laboratory (Figure 6-7). The SOP from BMFS was 
validated by previous research study using the same instrument as in this comparison study, 
the calibration model was evaluated as an appropriate quantitative analysis34. Conversely, 
MSP crime laboratory uses a different brand and model of LC-MS/MS and a lower 
concentration range of calibration curve for particular analytes, which contribute to the 
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disparity in the quantitative performance. Since the procedures developed by MSP have 
been previously validated using their instrumental method, approved protocol which 
slightly differs from the procedure used in this study, and applied to casework at their 
laboratory frequently, the applicability of their method should not be the major concern in 
this comparison. For codeine and oxycodone, although they have different regression 
models between SOPs, they performed similarly, given that the r2 values were above 0.99. 
Considering all factors, it was concluded that the SOP from MSP is not 100% reproducible 
in the BMFS laboratory for quantification.  
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Table 10. Calibration Model Coefficient of Determination (r2) using MSP’s SOP 
Compound 
Coefficient of Determination (r2) 
Run 1 Run 2 Run 3 Run 4 Run 5 
6-MAM 0.99906 0.99578 0.99844 0.99916 0.99728 
Codeine 0.99992 0.99864 0.99920 0.99932 0.99553 
Morphine 0.99924 0.99592 0.99772 0.99842 0.99003 
Fentanyl 0.89601 0.97608 0.97654 0.85892 0.99804 
Hydrocodone 0.99736 0.99668 0.99762 0.99874 0.99848 
Norhydrocodone 0.99902 0.99351 0.99786 0.99958 0.99856 
Oxycodone 0.99227 0.99778 0.99122 0.99834 0.99098 
Oxymorphone 0.99950 0.98784 0.99866 0.99816 0.99650 
*Quadratic regression model is highlighted in orange. 
**r2 value smaller than 0.99000 is highlighted in red.  
Table 11. Calibration Model Coefficient of Determination (r2) using BMFS’s SOP 
Compound 
Coefficient of Determination (r2) 
Run 1 Run 2 Run 3 Run 4 Run 5 
6-MAM 0.99986 0.99814 0.99523 0.99768 0.99828 
Codeine 0.99836 0.99846 0.99870 0.99922 0.99822 
Morphine 0.99928 0.99628 0.99495 0.99854 0.99786 
Fentanyl 0.99954 0.99728 0.99554 0.99954 0.99804 
Hydrocodone 0.99826 0.99736 0.99545 0.99918 0.99746 
Norhydrocodone 0.99898 0.99680 0.98637 0.99906 0.99846 
Oxycodone 0.99954 0.99357 0.99349 0.99862 0.99253 
Oxymorphone 0.99828 0.99576 0.99850 0.99876 0.99926 
*Quadratic regression model is highlighted in orange. 





Figure 6. Calibration model of fentanyl in linear regression model (MSP’s SOP). 
 




4.2 Bias and Precision 
 Bias and precision define the trueness, repeatability, and reproducibility of the 
confirmation analysis. From the SOP of MSP, all bias values passed the 20% acceptance 
range except for fentanyl at the concentration of LQC (20 ng/mL) (Table 12), which gave 
a 50% of inaccuracy. All analytes had the bias value within ±13% using BMFS’s SOP 
(Table 13).  
The highest value of calculated within-run %CV was used to evaluate the precision 
performance. its Within-run precisions for opioids were within 15% using MSP’s SOP, 
excluding fentanyl with about 24% at the LQC concentration (Table 14). For BMFS’s SOP, 
results demonstrated a lower within-run precisions for all analytes except 6-MAM, 
morphine, and fentanyl, varying from 5% to 13% (Table 15). However, a deviation up to 
29% was demonstrated for 6-MAM, morphine, and fentanyl (Table 15). By looking at the 
raw data, one of the three MQC replicates of all 5 runs had calculated concentration 
exceeding the quality control at ±50% for 6-MAM, morphine, and fentanyl, providing a 
massive deviation from the mean value in terms of the coefficient of variation in precision.  
 Using the SOP from MSP showed a better performance in between-run precision 
study, where all values were below 11% of variation, except a fentanyl value of 28% at the 
concentration of 20 ng/mL (Table 16). Data collected for the BMFS’s method was less 
precise over eight opioids at three concentrations. The variations varied from 5% to 22% 
(Table 17).  
Fentanyl was found not to meet the requirement in three standards when using the 
SOP from MSP. This could be explained by the calibration model established in this study, 
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which is not the most compatible regression model to fit with the instrument in laboratory 
(Section 4.1). An inappropriate regression model, as well as a less accepted calibration 
curve, may not accurately predict the actual concentration of the sample. Thus, it exhibited 
a high bias and low precision to the corresponding comparison.    
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Table 12. Bias Values using MSP’s SOP 
Compound 
Bias (%) 
LQC MQC HQC 
6-MAM 12.02 -4.85 -0.68 
Codeine 8.83 -6.86 -4.41 
Morphine 8.89 -7.74 -4.98 
Fentanyl 50.39 13.81 7.15 
Hydrocodone 14.71 1.00 -0.84 
Norhydrocodone 9.39 -3.76 -3.02 
Oxycodone 12.71 -1.90 -0.43 
Oxymorphone 10.78 -3.97 -0.44 
*Results that fell outside ±20% are highlighted in red.   
Table 13. Bias Values using BMFS’s SOP 
Compound Bias (%) LQC MQC HQC 
6-MAM 10.33 -0.94 3.14 
Codeine 12.40 2.58 3.36 
Morphine 6.48 1.46 4.02 
Fentanyl 7.33 -2.73 -1.75 
Hydrocodone 10.47 2.37 5.11 
Norhydrocodone 4.92 -3.39 -3.26 
Oxycodone 6.02 -2.14 1.29 



















































































































































































































































































































































































































































































































*The greatest within-run precision value in each concentration is highlighted.  
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*The greatest within-run precision value in each concentration is highlighted.  
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Table 16. Between-Run Precision Values using MSP’s SOP 
Compound Between-Run Precision (%CV) LQC MQC HQC 
6-MAM 4.81 4.92 6.29 
Codeine 4.23 6.28 9.91 
Morphine 5.20 5.63 6.04 
Fentanyl 27.43 7.78 5.84 
Hydrocodone 3.44 8.34 7.98 
Norhydrocodone 5.70 6.89 8.52 
Oxycodone 5.93 6.69 10.53 
Oxymorphone 5.05 7.80 7.81 
*Results that greater than 20% are highlighted in red.   
Table 17. Between-Run Precision Values using BMFS’s SOP 
Compound 
Between-Run Precision (%CV) 
LQC MQC HQC 
6-MAM 5.31 16.86 8.25 
Codeine 5.54 11.12 6.74 
Morphine 10.56 21.16 7.38 
Fentanyl 9.01 17.97 6.53 
Hydrocodone 4.38 13.36 6.60 
Norhydrocodone 9.28 14.00 10.93 
Oxycodone 12.63 10.61 7.25 
Oxymorphone 6.84 11.25 5.59 






Carryover was observed with codeine, fentanyl, and hydrocodone under the use of 
both methods (Table 18-19). At the same time, it was also observed with oxycodone 
demonstrated carryover in the analysis of BMFS sample preparation (Table 19). The 
presence of a false positive from the previous sample is more frequent while using BMFS’s 
SOP. In addition, carryover of fentanyl was also found in previous research using the 
method applied in BMFS34, therefore a closer investigation of the procedures and method 
developed should be conducted in future research to improve the qualitative performance.  
Since the abuse of fentanyl only requires a very low dosage, the lowest limit of 
quantification (LLOQ) of a validated method for fentanyl is usually set at a lower 
concentration, such as 0.5 ng/mL. As a result, the procedures for sample preparation have 








Value Run 1 
Decision 
Value Run 2 
Decision 
Value Run 3 
6-MAM 566.1 468.7 93.73 N/A 872.5 N/A 
Codeine 39.66 72.07 562.7 108.2 468.9 N/A 
Morphine 178.2 108.2 7.57 N/A 499.8 N/A 
Fentanyl 23700 231100 16800 39780 28990 83910 
Hydrocodone 407.4 324.5 2992 N/A 162.2 185.8 
Norhydrocodone 57.68 N/A 1130 350 1316 N/A 
Oxycodone 3046 2428 612.9 575.8 2244 N/A 
Oxymorphone 1880 464.5 175.9 N/A 3171 N/A 
*Signal area greater than 10% of Calibrator 1 is highlighted in red.  
 




Value Run 1 
Decision 
Value Run 2 
Decision 
Value Run 3 
6-MAM 193.3 N/A 97.37 N/A 14.42 N/A 
Codeine 43.27 36.07 54.05 216.4 40.85 216.4 
Morphine 18.01 N/A 36.22 N/A 39.65 N/A 
Fentanyl 5540 27560 4044 37200 2043 9504 
Hydrocodone 277.7 1009 352.7 937.5 201.9 1262 
Norhydrocodone 86.44 N/A 43.27 N/A 104.5 N/A 
Oxycodone 427.5 N/A 519.2 N/A 343.7 479.7 
Oxymorphone 229 N/A 169.1 N/A 147.3 N/A 




4.4 Interferences Studies 
 Interferences studies are vital in determining the specificity of a validated method. 
It is of utmost importance to forensic toxicology since misidentification or quantification 
of the types of drugs, such as prescription drugs, illegal drugs, or over-the-counter (OTC) 
drugs, may lead to various legal sentencing regulated by different jurisdictions. 
Furthermore, the sample matrix and the internal standards used have to be free from signal 
interferences at the particular analyte retention time.  
 In the matrix interference study, fentanyl failed to meet the accepted criteria for 
both SOPs, as sharp peak signals were noticed (Table 20-21). Drug analytes 6-MAM and 
morphine interference was detected in blank matrix while using the method adopted by 
BMFS (Table 21). Interferences were present in codeine and fentanyl in the detection of 
the highest calibrator in blank matrix for both SOPs (Table 22-23). In addition to the 
interference study of other commonly encountered drugs, fentanyl was detected in all three 
opioids-free mixes with BMFS’s SOP (Table 23).  
 There is insufficient research to explain the different interferences of specific types 
of opioids. However, one of the possible explanations could be the effect of carryover. In 
Section 4.3, results showed that fentanyl residue was detected in double blank sample while 
using both SOPs (Table 18-19). The interference identified could be passed from the 
previous sample injection. Although a blank sample was run prior to the double blank 
sample, the presence of peaks for analytes were discovered in both blank samples, 
indicating that the analytes from the highest calibrator (500 ng/mL) might be transferred to 
the following analysis through the analytical column.   
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*Signal area greater than LOQ is highlighted in red.
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*Signal area greater than LOQ is highlighted in red.  
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Table 22. Internal Standards and Other Analytes Interferences using MSP’s SOP 
Compound LOQ 
IS Interference Analytes Interference 
IS^ Highest Calibrator+ Mix 1 Mix 2 Mix 3 
6-MAM 937.3 N/A N/A 72.11 25.66 N/A 
Codeine 721 N/A 4506 N/A N/A N/A 
Morphine 75.7 N/A N/A N/A N/A N/A 
Fentanyl 174000 4032 305600 24750 7250 11140 
Hydrocodone 4074 108.2 34.49 N/A 216.3 N/A 
Norhydrocodone 1298 N/A 1370 N/A N/A N/A 
Oxycodone 6129 N/A N/A 324.4 324.5 504.8 
Oxymorphone 1759 N/A N/A N/A N/A N/A 
*Signal area greater than LOQ is highlighted in red. 
^Signal area of the quantifier ion. 
+Signal area of the internal standard. 
Table 23. Internal Standards and Other Analytes Interferences using BMFS’s SOP 
Compound LOQ 
IS Interference Analytes Interference 
IS^ Highest Calibrator+ Mix 1 Mix 2 Mix 3 
6-MAM 144.2 36.08 N/A N/A N/A N/A 
Codeine 36.05 N/A 102.7 N/A N/A N/A 
Morphine 72.13 N/A N/A N/A N/A N/A 
Fentanyl 24140 1180 42510 74520 67100 71980 
Hydrocodone 324.6 108.2 36.06 N/A N/A N/A 
Norhydrocodone 288.4 N/A 180.3 N/A N/A N/A 
Oxycodone 431.3 N/A N/A N/A N/A N/A 
Oxymorphone 136.4 72.02 N/A N/A N/A N/A 
*Signal area greater than LOQ is highlighted in red.  
^Signal area of the quantifier ion. 





4.5 Ionization Suppression/ Enhancement 
 Co-eluting species from matrix components that can suppress or enhance the 
ionization of the target analyte, associated with LC-MS analysis, and is defined as matrix 
effect.35-36 It also diminishes the measurements of bias and precision by the detection of 
signal peaks, as a consequence of limiting quantification.37  The degree of suppression or 
enhancement was measured by the ratio of average signal from neat standards to the 
average signal from post-extraction spikes.  
In this comparison study, the SOP applied in BMFS had less effect on ionization 
suppression or enhancement at low concentration. Ionization suppression occurred ranging 
from 25% to 34% using MSP’s SOP (Table 24). Conversely, the SOP from MSP presented 
mild effect from co-eluting matrix components at high concentration. Fentanyl ion was 
found suppressed at ~42% using BMFS method (Table 24).  
Other research showed that ESI more susceptible to matrix effects than 
atmospheric-pressure chemical ionization (APCI) due to the presence of components with 
a wide range of polarities.37 During ESI, ion intensity can be altered in several ways: matrix 
components compete with target analyte to gain charge, increase the surface tension of 
droplets that prevent further Coulombic fission (Section 1.5.2), and/or impact the stability 
of ions generated in gas phase.38 
 SPE is often given as a method to diminish matrix effects with the help of LC-ESI-
MS/MS. Matrix clean-up is more extensive with SPE, and it also concentrates the 
interfering substances that have similar functional groups to the target analytes. As a result, 
it may enhance matrix effects.37 A study also found that residues in plasma have a higher 
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concentration of hydrophilic and hydrophobic components that contribute 35–50% of 
ionization suppression.37 
 Although research has shown that co-eluting isotope-labeled internal standards 
suppressed ionization of their corresponding target drugs in ESI mode, insufficient analysis 
or review is able to explain the differences of sample preparation relevant to the differences 
of matrix effect in low and high concentrations.39  
Table 24. Results of Ionization Suppression/ Enhancement  
Compound Low Concentration (%) High Concentration (%) 
MSP BMFS MSP BMFS 
6-MAM -25.98 0.87 -0.90 -21.23 
Codeine -27.78 -6.78 -4.36 -34.48 
Morphine 16.87 2.98 -3.24 -18.80 
Fentanyl -4.15 -16.29 -4.74 -42.32 
Hydrocodone -26.52 -6.68 -5.76 -34.93 
Norhydrocodone -34.24 -23.08 -5.13 -34.58 
Oxycodone -23.32 -8.30 -12.2 -28.96 
Oxymorphone -26.56 -6.00 -4.86 -20.94 





Recovery evaluates the efficiency or robustness of the extraction method employed 
in analysis. Extraction efficiency can be affected by the sample pH, the adsorbent type in 
SPE column, and the selection of elution solvents.40  
  Pre-extraction spike and post-extraction spike were used in determining the 
analytes’ recoveries at two concentrations. A minimum of 50% recovery is preferred in 
forensic toxicology. The SOP adopted by MSP presented better recovery in extraction at 
both concentrations, giving a majority of 80% and up to 93% (Table 25). Nonetheless, 
analytes of 6-MAM, morphine, and fentanyl were recovered at about 40% in blood while 
following the procedures suggested by BMFS. The recovery of other analytes was about 
average, ranging from 60% to 78% (Table 25).  
In order to achieve maximum enrichment, the factors of sample volume and type, 
cartridge’s characteristics, nature and volume of the washing eluent, and the volume of 
solvent used to collect the analytes should be taken into account.21 Research suggests that 
the volume of solvent used in the washing step should be as low as possible to prevent 
breakthrough to the SPE cartridge.21 At the same time, the volume of solvent in the elution 
step should be low as well.21 The size of the packing material in the cartridge determines 
the volume of solvent used for better desorption and reproducibility. As the volume of 
elution solvent from MSP’s SOP is 1mL lower than those from BMFS, it may explain the 




Table 25. Results of Recovery  
Compound Low Concentration (%) High Concentration (%) 
MSP BMFS MSP BMFS 
6-MAM 84.98 45.33 76.40 50.91 
Codeine 85.79 62.66 81.32 77.69 
Morphine 87.08 40.26 72.37 45.84 
Fentanyl 46.60 46.27 83.24 62.98 
Hydrocodone 86.55 64.13 83.01 78.61 
Norhydrocodone 80.46 72.39 78.69 87.45 
Oxycodone 93.73 70.33 83.76 83.51 
Oxymorphone 85.09 64.58 78.93 81.57 






 The purpose of this comparison study was to evaluate the performance of opioid 
detection in blood in the different SOP applications, using the parameters in method 
validation according to the ASB guidelines. The procedures for sample pre-treatment and 
SPE were compared while the quantification method was kept constant. The eight opioids 
included 6-MAM, codeine, fentanyl, hydrocodone, morphine, norhydrocodone, 
oxycodone, and oxymorphone.  
 The use of MSP’s SOP exhibited a better performance in the determination of 
between-run precision, interferences from matrix and other commonly encountered drug 
analytes, matrix effect at high concentration, and  recovery at low and high concentration. 
Conversely, the results from BMFS’s SOP showed an advantage in calibration model, bias, 
within-run precision and ionization suppression/enhancement at low concentration. For the 
calibration model, an appropriate regression model should be chosen considering the 
instrument itself and the quantitative performance of particular drug analytes. The 
calibration model affects quantitation of an analyte, as well as impacts the results for other 
parameters in calculating the actual concentration, therefore the SOP from BMFS could 
show a better accuracy in quantification and those from MSP could be more preferred in 
qualification. Ionization suppression/enhancement can also influence the parameters of 
bias and precision. In this study, two SOPs performed differently in matrix effect 
examination at particular concentration, while this might suggest the variations on their 
performances for bias and precision. Carryover and the interference from internal standard 
did not show a great disparity between the two validated methods. Both methods showed 
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certain carryover with codeine, fentanyl and hydrocodone, as well as interfering substances 
with codeine and fentanyl.  
 Although applying the SOP from MSP gave a better qualitative and quantitative 
performance in the detection of opioids, it also utilized more solvents, working solution 
and time during sample preparation. In sample pre-treatment and SPE, MSP used 2.5 times 
more working solution and approximately 2 mL more solvent for each addition. The larger 
volume of solvents applied, the longer of time is needed to elute through the cartridge 
during extraction. When the batch of samples are large in quantity, the entire analysis 
would be more costly and timely by adopting the MSP SOP.  
 Furthermore, the volume of blood needed was 500 µL for MSP but 200 µL for 
BMFS. A large of quantity of blood can be withdrawn easily during autopsy as sample 
collection in forensic toxicology. However, if postmortem blood is limited or only 
antemortem blood is available, the amount of blood needed would be a determining factor 
in analysis as ionization suppression/enhancement and matrix interference are correlated 
to the sample matrix. In addition to the comparison parameters, cost, and time required, the 
overall reproducibility and reliability of each method was considered based on the 
instrumentation and the laboratory environment, showing that both SOPs were comparable.   
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6. FURTHER RESEARCH 
 Further research could be conducted on the comparison of SOPs for the detection 
of other classes of drugs, for example amphetamines, benzodiazepines, cannabinols, and 
hallucinogens. It would be beneficial to develop a method which could optimize the 
qualitative and quantitative performance specifically for each class of drug, use in forensic 
applications. A comparison study could also be performed on a different matrix, such as 
urine or tissue samples that are frequently collected in forensic toxicology.  
 In addition to the distinctions discovered with the two SOPs, the type of ionization 
in tandem mass spectrometry could also be an aspect in future method assessment. As 
different ionization types were found to suppress or enhance the ionization, APCI could be 
utilized to examine matrix effects using both SOPs.  
 Specifically focusing on the calibration model of fentanyl in MSP’s SOP, an 
alteration of regression model to quadratic could be made. Another comparison study could 
be conducted in order to determine if the change of model helps analyte quantification by 




APPENDIX A: CHROMATOGRAM 
 
Figure A: Chromatogram of Analytes. Mid-quality control analytes at 150 ng/mL and 
internal standards at 2,000 ng/mL. Peaks from the left to right: morphine-d6, morphine, 
oxymorphone-d3, oxymorphone, oxycodone-d3, oxycodone, norhydrocodone-d3, 
norhydrocodone, 6-MAM-d6, 6-MAM, codeine-d3, codeine, hydrocodone-d6, 




APPENDIX B: MS/MS METHOD 
Table A: Compound Transitions and Retention Times 
Analytes and IS Transition Retention Time 
6-MAM quant 328 -> 165.3  
1.90 6-MAM qual 328 -> 152.1 
6-MAM-d6 334.1 -> 211.1 
Codeine quant 300.3 -> 152.1  
2.01 Codeine qual 300.3 -> 115.3 
Codeine-d3 306.2 -> 152.2 
Morphine quant 286.3 -> 152.1  
0.94 Morphine qual 286.3 -> 115.2 
Morphine-d6 292.3 -> 152 
Fentanyl quant 337.2 -> 105.1  
5.10 Fentanyl qual 337.2 -> 188.3 
Fentanyl-d5 342.2 -> 105.2 
Hydrocodone quant 300.215 -> 199.1  
2.02 Hydrocodone qual 300.215 -> 128 
Hydrocodone-d6 305.7 -> 202.1 
Norhydrocodone quant 286.2 -> 199.1  
1.84 Norhydrocodone qual 286.2 -> 128.3 
Norhydrocodone-d3 289.15 -> 202.2 
Oxycodone quant 316.2 -> 298.5  
1.82 Oxycodone qual 316.2 -> 241.3 
Oxycodone-d3 322.1 -> 304.1 
Oxymorphone quant 302.2 -> 284.2  
1.08 Oxymorphone qual 302.2 -> 227.2 





APPENDIX C: LC-MS/MS INSTRUMENTAL PARAMETERS OF MSP’S SOP 
Table A: LC Mobile Phase Gradient Method 
Time % Mobile Phase A % Mobile Phase B 
0.50 95 5 
2.00 80 20 
2.80 80 20 
4.00 10 90 
4.50 10 90 
5.00 95 5 
5.50 Stop 
 
Table B. Autosampler (SIL-20AC/HT) Parameters 
Injection Volume 5 µL 
Total Flow 0.55 mL/min 
Rinsing Volume 300 µL 
Needle Stroke 48 mm 
Rinsing Speed 35 µL/sec 
Sampling Speed 5.0 µL/sec 
Purge Time 25 min 
Rinse Dip Time 5 sec 
Rinse Mode After aspiration 





Table C. MS/MS (MRM) Method Parameters  













6-MAM quant 328.164 165.1 66 47 22 2.74 6-MAM qual 328.164 211.2 66 32 19.43 
6-MAM-d6 334.211 165.2 211.2 66 
47 
32 22 2.73 
Codeine quant 299.829 152.1 71 79 18 2.59 Codeine qual 299.829 165.2 71 59 18 





Morphine quant 286.516 152.1 71 60 18 1.35 Morphine qual 286.416 128.1 71 60 18 
Morphine-d6 292.169 128.2 153.1 76 
71 
53 16 1.32 
Fentanyl quant 337.219 105.2 61 30 19.68 4.36 
Fentanyl qual 337.219 188.1 61 16 26 4.35 





Hydrocodone quant 299.850 199.1 71 20 18 2.90 Hydrocodone qual 299.850 128.1 71 50 18 
Hydrocodone-d6 305.865 202.2 128.1 71 
25 
55 18 2.88 
Norhydrocodone 
quant 285.747 199.2 51 20 16  2.73 
 Norhydrocodone qual 285.747 115.2 51 55 16 





Oxycodone quant 316.034 241.2 21 35 38 2.79 Oxycodone qual 316.034 212.2 41 53 19.09 
Oxycodone-d3 319.191 244.2 115.3 56 
33 
111 18 2.78 
Oxymorphone quant 301.871 227.2 56 37 18.7 1.60 Oxymorphone qual 301.871 198.1 56 53 18 
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